INTERNATIONAL PATENT: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE, ASSISTANCE PUBLIQUE-HÔPITAUX DE PARIS (APHP), INSTITUT PASTEUR, UNIVERSITE PARIS CITE, UNIVERSITE DES ANTILLES ET DE LA GUYANE FILES APPLICATION FOR "RAVIDASVIR, VELPATASVIR AND ELBASVIR FOR BLOCKING TRANSMISSION OF PLASMODIUM GAMETOCYTES"

GENEVA, Aug. 11 -- INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (101, rue de Tolbiac75013 Paris), ASSISTANCE PUBLIQUE-HÔPITAUX DE PARIS (APHP) (55 boulevard Diderot75012 Paris), INSTITUT PASTEUR (25-28, rue du Docteur Roux75015 PARIS), UNIVERSITE PARIS CITE (85 Boulevard Saint-Germain75006 Paris), UNIVERSITE DES ANTILLES ET DE LA GUYANE (CAMPUS FOUILLOLE97110 Pointe-a-Pitre) filed a patent application (PCT/EP2025/052078) for "RAVIDASVIR, VELPATASVIR, AND ELBASVIR FOR BLOCKING TRANSMISSION OF PLASMODIUM GAMETOCYTES" on Jan 28, 2025. With publication no. WO/2025/162911, the details related to the patent application was published on Aug 07, 2025.

Notably, the patent application was submitted under the International Patent Cl...